Nevanac Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Nepafenac

Indications/Uses

Prevention & treatment of post-op pain & inflammation associated w/ cataract surgery. Reduction in the risk of post-op macular oedema associated w/ cataract surgery in diabetic patients.

Dosage/Direction for Use

Adult & elderly Prevention & treatment of post-op pain & inflammation associated w/ cataract surgery 1 drop in the conjunctival sac of affected eye(s) tds beginning 1 day prior to cataract surgery. Continue on the day of surgery for the 1st 2 wk of post-op period. Administer an additional drop 30-120 min prior to surgery. Diabetic patient Reduction in the risk of post-op macular oedema 1 drop in the conjunctival sac of the affected eye(s) tds beginning 1 day prior to cataract surgery. Continue on the day of surgery up to 60 days of post-op period. Administer an additional drop 30-120 min prior to surgery.

Contraindications

Hypersensitivity to nepafenac or other NSAIDs. Patients in whom attacks of asthma, urticaria or acute rhinitis are precipitated by ASA or other NSAIDs.

MIMS Class

Ophthalmic Decongestants, Anesthetics, Anti-Inflammatories

ATC Classification

S01BC10 - nepafenac ; Belongs to the class of non-steroidal antiinflammatory agents. Used in the treatment of inflammation of the eye.

Regulatory Classification

POM

Presentation/Packing

Form

Nevanac ophth susp 1 mg/mL

Packing/Price

1's

Nevanac

nepafenac

Manufacturer:

Novartis Manufacturing NV